Cold-chain handling and storage for lyophilised research peptides

Temperature is the single largest factor in preserving the quality of lyophilised research peptides between the moment a vial leaves the supplier and the moment it reaches the bench. Peptides are chains of amino acids held together by bonds that can break, rearrange, or clump together when energy enters the system, and warmth adds that energy. Keeping material cold slows the processes that would otherwise shorten the usable life of a sample, which is why cold-chain discipline matters at every step from packing through to long-term storage.

This note covers the laboratory handling and storage of lyophilised (dry) powder and reconstituted solution as research material only. It explains why temperature governs stability, the temperatures commonly used for storage, why repeated freezing and thawing damages a sample, how to shield material from light and moisture, and what to inspect when a cold-shipped parcel arrives.

For laboratory research use only. Not for human or veterinary use.

Why temperature governs peptide stability

Peptide material degrades through several routes that all speed up as temperature rises. Water-driven cleavage of the backbone, oxidation of sensitive residues such as methionine and cysteine, deamidation of asparagine and glutamine, and aggregation of chains into insoluble clusters are the common failure modes. Each is a chemical reaction, and reaction rates climb sharply with heat, so a sample held cold can last many times longer than the same sample left warm.

Lyophilisation, or freeze-drying, removes almost all of the water from a sample and leaves a dry cake or film in the vial. Because water is the main driver of hydrolysis and a partner in many other breakdown reactions, the dry state is far more stable than any solution. That is why material is shipped and stored as a powder, and why the cold chain and the moisture barrier both need to hold until the vial is opened.

Storing dry powder versus reconstituted solution

Sealed lyophilised powder is the most robust form the material takes. Kept cold, dry, and away from light in its original stoppered vial, a powder can remain usable for long periods. Leave the stopper and seal undisturbed until you are ready to work, keep a desiccant nearby, and avoid opening the vial more often than the work requires.

Once a powder is brought into solution it becomes far more fragile, because the water that was removed is now back in contact with every peptide bond. A reconstituted solution should be kept refrigerated, shielded from light, and used within a short working window rather than stored for months. Splitting a solution into small single-use aliquots at the point of preparation is the most effective way to limit how often any one portion is warmed or frozen.

For preparing solution from powder in a consistent way across a group, follow a documented reconstitution procedure so volumes, solvents, and handling stay the same each time and results are easier to compare.

Stock the desiccant packs, amber or foil-wrapped tubes, cryo-safe aliquot vials, and sealed bags you will need from your consumables supply before material arrives, so nothing sits out at room temperature while you hunt for the right container.

Typical storage temperatures

The right temperature depends on the form of the material and how long it needs to sit before use. The ranges below are a common starting point for laboratory storage.

• Room temperature: used only briefly, mainly to let a cold sealed vial equalise before it is opened, which limits condensation on the cold glass. It is not a storage state.
• 2 to 8 C (refrigeration): suitable for short-term working storage, such as a reconstituted solution in active use or a powder that will be opened again within days to a couple of weeks.
• Minus 20 C (freezer): a common choice for medium to longer term storage of dry powder and of aliquots that will not be needed for weeks or months.
• Minus 80 C (ultra-low freezer): reserved for the longest-term archival storage, where a sample must stay in reserve for many months or years with the slowest possible rate of change.

Why freeze-thaw cycles degrade material

Colder is generally safer, but the act of freezing and thawing repeatedly is its own source of damage. As a solution freezes, ice crystals form and grow, and the peptide together with any buffer salts is pushed into the shrinking volume of liquid that has not yet frozen. That local crowding raises the effective concentration and can shift the local pH, both of which push chains toward aggregation, while the crystals apply mechanical stress at surfaces where material can unfold and stick together. Each freeze and each thaw repeats this insult, so a sample cycled many times can show far more loss than its total time in the freezer would suggest.

The practical answer is to freeze in small single-use aliquots so each portion is thawed once and then finished. Thaw gently, on ice or in a refrigerator rather than under hot water, mix gently rather than shaking hard, and never refreeze a portion that has already been warmed.

Protecting from light and moisture

Light, and ultraviolet light in particular, can drive oxidation of sensitive residues, so material is best kept in amber vials, wrapped in foil, or simply stored in the dark. Moisture is the other quiet threat. A freeze-dried powder is often hygroscopic, meaning it readily draws water out of the air, and even a small amount of absorbed moisture can restart the reactions the dry state was meant to prevent. Keep vials sealed, store a desiccant with the material, and let a cold vial reach room temperature while still sealed before opening, so water does not condense onto cold glass or powder. Once open, work quickly and reseal promptly.

Checking a cold-shipped parcel on arrival

A cold-shipped parcel should be opened and checked as soon as it arrives, before it is stored away. Work through a short receiving routine:

• Inspect the outer packaging for crushing, punctures, or water damage that might point to rough transit or a broken seal.
• Check the coolant. Gel packs should still be cold and any dry ice should still be present, since fully warmed coolant suggests the parcel spent too long in transit.
• Examine each vial. Confirm the glass is intact, the stopper and seal are seated, and the powder looks as expected as a pellet, cake, or film with no obvious liquid or moisture.
• Match the labels and paperwork against your order, checking identity, quantity, and any lot or batch numbers.
• Move the material into its correct storage promptly, then log the receipt with the date, condition on arrival, and any temperature excursion so the record is available if a question comes up later.

If anything looks wrong, from warmed coolant to a cracked vial or a mismatched label, set the material aside and contact the supplier before using it rather than assuming the sample is sound.

Common questions

Can lyophilised powder sit at room temperature during shipping?

Short, insulated transit with coolant is generally tolerated because the dry state is stable and the packing keeps the parcel cold for the trip. What matters is limiting how long and how warm that exposure is, and moving the material into cold storage as soon as it arrives.

Should I refrigerate or freeze an unopened vial?

For a sealed powder you expect to open within a couple of weeks, 2 to 8 C is convenient. If it will sit for weeks or months, minus 20 C is the more common choice, and minus 80 C suits long archival storage. Follow the supplier storage statement on the label where one is given, and keep the vial sealed and dry.

How do I avoid freeze-thaw damage to a reconstituted solution?

Split the solution into small single-use aliquots at the moment it is prepared, label each with contents and date, and freeze them separately. Pull one aliquot at a time, thaw it gently on ice, and finish it rather than returning the leftover to the freezer. That way no portion is cycled more than once.

References

1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of Protein Pharmaceuticals: An Update. Pharmaceutical Research. 2010;27(4):544-575.
2. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999;185(2):129-188.